Prometheus Biosciences, Inc. Email Format
Biotechnology ResearchCalifornia, United States51-200 Employees
Headquartered in San Diego, California, Prometheus operates as a mid-sized player in the biotechnology research field. In 2023, the company announced the launch of Phase 3 studies for PRA023, a program targeting ulcerative colitis, Crohn's disease, and other immune-mediated diseases.